Dermaprazole Cream for Radiation Dermatitis in Head and Neck Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

June 15, 2022

Primary Completion Date

June 18, 2024

Study Completion Date

June 18, 2024

Conditions
Cancer of the Head and Neck
Interventions
DRUG

Dermaprazole

Patients will be managed with twice daily prophylactic use of the proposed intervention (Dermaprazole) topical cream for radiation dermatitis. The amount of cream will be 2cc per application and will be measured in pre-filled capped syringes for every application.

DRUG

Aquaphor

Patients will be managed with twice daily prophylactic use of Aquaphor. The amount of Aquaphor will be 2cc per application and will be measured in pre-filled capped syringes for every application.

Trial Locations (1)

78229

Mays Cancer Center, San Antonio

All Listed Sponsors
lead

The University of Texas Health Science Center at San Antonio

OTHER